Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen Inc. Challenges Eli Lilly and Novo Nordisk in Weight Loss Drug Wars

December 03, 2024
Amgen Inc. (NASDAQ: AMGN) has entered the weight loss drug market, taking on the industry giants Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO). With its recent announcement, Amgen is attracting investor attention. The company's move into the weight loss drug sector is expected to disrupt Novo Nordisk's dominance and challenge Eli Lilly's position in the market. This bold step by Amgen has raised curiosity among investors and industry experts, who are now closely monitoring its progress. While the outcome is uncertain, considering Amgen's track record and expertise in developing innovative drugs, many are optimistic about the company's potential success in this new venture. To stay updated with the latest developments and receive professional insights on the forecast of Amgen's stock movement, investors are recommended to consult professionals from Stocks Prognosis.

Find out how the AMGEN INC. rate is expected to change

Get Forecast for AMGN

Investor opinions & comments:

Amgen's announcement has certainly piqued my interest. I'm looking forward to seeing how they will fare against Eli Lilly and Novo Nordisk
— from ThomasHawkins at 12-07-2024 06:52
This is a promising development for Amgen. Their expertise in drug development could give them an edge in the weight loss drug market
— from JonathanPowell at 12-07-2024 05:03
I'm not so sure about Amgen's chances in the weight loss drug market. Eli Lilly and Novo Nordisk have a strong hold on the industry
— from WealthyWillie at 12-07-2024 04:50
I think Amgen's entry into the weight loss drug market is a smart strategic move. They have a chance to disrupt the industry
— from JamesThomas at 12-06-2024 20:40
Amgen's move into the weight loss drug market is a smart business decision. I'm excited to see how they will shake up the industry
— from JessicaHall at 12-06-2024 18:18
Amgen may have a track record of developing innovative drugs, but that doesn't guarantee success in the weight loss drug market
— from GrowthGreg at 12-06-2024 17:28
I'm curious to see how Amgen's expertise in developing innovative drugs will play out in the weight loss drug sector. This could be a game-changer
— from WealthyWhitney at 12-06-2024 17:01
This is a great move by Amgen to enter the weight loss drug market. I'm excited to see how they will disrupt Novo Nordisk's dominance
— from WealthyWyatt at 12-06-2024 10:25
I think Amgen has the potential to challenge Eli Lilly's position in the market. It's definitely worth keeping an eye on their progress
— from MarketMegan at 12-06-2024 08:27
It's refreshing to see a new player like Amgen challenge the dominance of Eli Lilly and Novo Nordisk in the weight loss drug market
— from CapitalChris at 12-06-2024 02:33
Amgen's foray into the weight loss drug market is a calculated risk that could lead to great rewards. I'm definitely keeping an eye on their progress
— from InvestorImogen at 12-05-2024 18:17
Amgen's track record speaks for itself. I wouldn't underestimate their chances in the weight loss drug market
— from PennyInvestor at 12-05-2024 15:30
I'm optimistic about Amgen's potential success in the weight loss drug market. They have the expertise and resources to make a strong impact
— from RobertWhite at 12-05-2024 14:47
As an investor, I think it's wise to closely monitor Amgen's progress in the weight loss drug market. They could be a game-changer
— from CashCathy at 12-05-2024 12:22
Amgen's entry into the weight loss drug market is a bold move that could pay off. It will be interesting to see how the competition unfolds
— from TraderTina at 12-05-2024 01:44
I have high hopes for Amgen in the weight loss drug market. They have the potential to offer innovative solutions
— from SavingsSam at 12-04-2024 22:42
Entering a market dominated by giants like Eli Lilly and Novo Nordisk is no small feat. It remains to be seen if Amgen can truly challenge them
— from ThomasHawkins at 12-04-2024 04:20
I'm excited to see how Amgen's entry into the weight loss drug market will shake things up. It's always good to have competition
— from TylerGonzalez at 12-04-2024 03:47
Amgen's move into the weight loss drug market is bold and admirable. I'm optimistic about their potential success
— from MatthewGarcia at 12-03-2024 20:39
If you want to leave a comment, then you need Login or Register





Other news for AMGN

AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....



Related news

BIIBDecember 10, 2024Biogen Inc BIIBs Uncertain Future: Understanding the Barriers  ~2 min.

Biogen Inc, a leading biotechnology company, is currently facing an uncertain future as it grapples with several barriers to outperformance....

CVSFebruary 8, 2025CVS Health's Stock Rallying Despite Ambiguous Financials: Will It Continue?  ~2 min.

CVS Health Corporation's stock (NYSE: CVS) has been experiencing a significant rally in recent weeks. However, the financial situation of the company appears to be somewhat uncertain....

BBYJanuary 1, 2025Best Buy Faces Uncertain Future with Potential Investment Risks  ~2 min.

Investors who bought shares in Best Buy three years ago are facing losses as the company's stock price has dropped significantly....

WMTMarch 22, 2025Walmart Inc. WMT: Walmart Left Me Feeling Uncertain And Thats a Problem - Jim Cramer Calls Out the Retail Giant  ~1 min.

Walmart Inc. (NYSE: WMT) has been under scrutiny after Jim Cramer, a well-known financial analyst, called out the retail giant for its uncertain performance....

MUFebruary 3, 2025Micron Technology Faces Uncertain Future, warns Jim Cramer  ~2 min.

Micron Technology Inc., a leading global provider of semiconductor solutions, is facing a challenging time, according to renowned financial expert Jim Cramer....